{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:44:53Z","timestamp":1771073093727,"version":"3.50.1"},"reference-count":52,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1210\/en.2017-00027","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:25:30Z","timestamp":1492615530000},"page":"1701-1714","source":"Crossref","is-referenced-by-count":18,"title":["Incretin Therapies Do Not Expand \u03b2-Cell Mass or Alter Pancreatic Histology in Young Male Mice"],"prefix":"10.1210","volume":"158","author":[{"given":"Aaron R.","family":"Cox","sequence":"first","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Lam","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Rankin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline S.","family":"Rios","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Chavez","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire W.","family":"Bonnyman","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourtney B.","family":"King","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger A.","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Cellular, Molecular, and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire 03824"},{"name":"Consulting Tox\/Path Services, Kittery, Maine 03904"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Anthony","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin X.","family":"Tu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhong","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake A.","family":"Kushner","sequence":"additional","affiliation":[{"name":"McNair Medical Institute, Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,3,8]]},"reference":[{"issue":"8","key":"2019041121542716400_B1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041121542716400_B2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"issue":"9548","key":"2019041121542716400_B3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"2019041121542716400_B4","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"2019041121542716400_B5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db05-0825","article-title":"Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass","volume":"55","author":"Buteau","year":"2006","journal-title":"Diabetes"},{"issue":"6","key":"2019041121542716400_B6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2337\/db08-1198","article-title":"Adaptive beta-cell proliferation is severely restricted with advanced age","volume":"58","author":"Rankin","year":"2009","journal-title":"Diabetes"},{"key":"2019041121542716400_B7","doi-asserted-by":"crossref","unstructured":"Tschen SI, Dhawan S, Gurlo T, Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes. 2009;58(6):1312\u20131320.","DOI":"10.2337\/db08-1651"},{"key":"2019041121542716400_B8","doi-asserted-by":"crossref","unstructured":"Tschen SI, Georgia S, Dhawan S, Bhushan A. Skp2 is required for incretin hormone-mediated \u03b2-cell proliferation. Mol Endocrinol. 2011;25(12):2134\u20132143.","DOI":"10.1210\/me.2011-1119"},{"issue":"5","key":"2019041121542716400_B9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.devcel.2007.04.011","article-title":"Growth and regeneration of adult beta cells does not involve specialized progenitors","volume":"12","author":"Teta","year":"2007","journal-title":"Dev Cell"},{"issue":"2-3","key":"2019041121542716400_B10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejphar.2010.10.062","article-title":"The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats","volume":"650","author":"Duttaroy","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2019041121542716400_B11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","article-title":"Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice","volume":"45","author":"Wang","year":"2002","journal-title":"Diabetologia"},{"issue":"6","key":"2019041121542716400_B12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/db05-1602","article-title":"Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes","volume":"55","author":"Mu","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"2019041121542716400_B13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabres.2011.01.016","article-title":"Effect of sitagliptin plus metformin on \u03b2-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats","volume":"92","author":"Han","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2019041121542716400_B14","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diabetes.50.7.1562","article-title":"Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age","volume":"50","author":"Tourrel","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"2019041121542716400_B15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.52.3.741","article-title":"Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats","volume":"52","author":"Pospisilik","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"2019041121542716400_B16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diabres.2005.11.007","article-title":"GLP-1\/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts","volume":"73","author":"Xu","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2019041121542716400_B17","doi-asserted-by":"crossref","first-page":"e53345","DOI":"10.1371\/journal.pone.0053345","article-title":"Stimulating \u03b2-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor","volume":"8","author":"Ansarullah","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2019041121542716400_B18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbrc.2009.10.054","article-title":"Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents","volume":"390","author":"Arakawa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2019041121542716400_B19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"2019041121542716400_B20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","article-title":"Exenatide (exendin-4)-induced pancreatitis: a case report","volume":"29","author":"Denker","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"2019041121542716400_B21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.diabres.2015.02.013","article-title":"Incretin-based drugs and risk of acute pancreatitis: a nested-case control study within a healthcare database","volume":"108","author":"Soranna","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2019041121542716400_B22","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"key":"2019041121542716400_B23","doi-asserted-by":"crossref","unstructured":"Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes. 2009;58(7):1604\u20131615.","DOI":"10.2337\/db09-0058"},{"issue":"5","key":"2019041121542716400_B24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model","volume":"61","author":"Gier","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"2019041121542716400_B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/jm0493156","article-title":"(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Kim","year":"2005","journal-title":"J Med Chem"},{"issue":"46","key":"2019041121542716400_B26","first-page":"2166.","article-title":"Immunofluorescent detection of two thymidine analogues (CldU and IdU) in primary tissue","volume":"7","author":"Tuttle","year":"2010","journal-title":"J Vis Exp"},{"issue":"5","key":"2019041121542716400_B27","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db12-0848","article-title":"\u03b2-Cells are not generated in pancreatic duct ligation-induced injury in adult mice","volume":"62","author":"Rankin","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"2019041121542716400_B28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/me.2009-0057","article-title":"Cyclin D2 protein stability is regulated in pancreatic beta-cells","volume":"23","author":"He","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"10","key":"2019041121542716400_B29","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1371\/journal.pmed.0050206","article-title":"Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells","volume":"5","author":"Remedi","year":"2008","journal-title":"PLoS Med"},{"issue":"40","key":"2019041121542716400_B30","doi-asserted-by":"crossref","first-page":"37176","DOI":"10.1074\/jbc.M206757200","article-title":"Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose","volume":"277","author":"Shiota","year":"2002","journal-title":"J Biol Chem"},{"issue":"13","key":"2019041121542716400_B31","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1074\/jbc.275.13.9270","article-title":"Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion","volume":"275","author":"Seghers","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121542716400_B32","article-title":"Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass","author":"Portha","journal-title":"Exp Diabetes Res"},{"issue":"3","key":"2019041121542716400_B33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2013.04.006","article-title":"GLP-1 agonists in type 1 diabetes","volume":"149","author":"Pettus","year":"2013","journal-title":"Clin Immunol"},{"issue":"2","key":"2019041121542716400_B34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"issue":"6","key":"2019041121542716400_B35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res"},{"issue":"10","key":"2019041121542716400_B36","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1463-1326.2012.01619.x","article-title":"Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic \u03b2-cell mass in a streptozotocin-induced mouse model of type 2 diabetes","volume":"14","author":"Poucher","year":"2012","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2019041121542716400_B37","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2004-0015","article-title":"Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system","volume":"145","author":"Brubaker","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"2019041121542716400_B38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tem.2016.03.004","article-title":"Glucagon-like peptide 1 analogs and their effects on pancreatic islets","volume":"27","author":"Tudur\u00ed","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2019041121542716400_B39","doi-asserted-by":"crossref","first-page":"T43","DOI":"10.1530\/JOE-13-0577","article-title":"Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?","volume":"221","author":"Lamont","year":"2014","journal-title":"J Endocrinol"},{"issue":"6","key":"2019041121542716400_B40","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2337\/db07-1369","article-title":"Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans","volume":"57","author":"Meier","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"2019041121542716400_B41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4161\/isl.2.6.13376","article-title":"Aging induces a distinct gene expression program in mouse islets","volume":"2","author":"Rankin","year":"2010","journal-title":"Islets"},{"issue":"6","key":"2019041121542716400_B42","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00125-016-3922-7","article-title":"Extreme obesity induces massive beta cell expansion in mice through self-renewal and does not alter the beta cell lineage","volume":"59","author":"Cox","year":"2016","journal-title":"Diabetologia"},{"issue":"7","key":"2019041121542716400_B43","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00125-015-3590-z","article-title":"Angiopoietin-like protein 8 (ANGPTL8)\/betatrophin overexpression does not increase beta cell proliferation in mice","volume":"58","author":"Cox","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"2019041121542716400_B44","doi-asserted-by":"crossref","first-page":"E475","DOI":"10.1152\/ajpendo.00025.2013","article-title":"One year of sitagliptin treatment protects against islet amyloid-associated \u03b2-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice","volume":"305","author":"Aston-Mourney","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2019041121542716400_B45","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/db13-1268","article-title":"Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies","volume":"63","author":"Chadwick","year":"2014","journal-title":"Diabetes"},{"issue":"10","key":"2019041121542716400_B46","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2337\/db13-0690","article-title":"Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes. 2013;62:2595\u20132604","volume":"62","author":"Heine","year":"2013","journal-title":"Diabetes"},{"issue":"10","key":"2019041121542716400_B47","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2337\/db13-0525","article-title":"Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595\u20132604","volume":"62","author":"Engel","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"2019041121542716400_B48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/dom.12257","article-title":"Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies","volume":"16","author":"Bonner-Weir","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"2019041121542716400_B49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2013.0177","article-title":"An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology","volume":"15","author":"Harja","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2019041121542716400_B50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2014.01.021","article-title":"High fat diet and GLP-1 drugs induce pancreatic injury in mice","volume":"276","author":"Rouse","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"2019041121542716400_B51","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/db09-0626","article-title":"Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice","volume":"58","author":"Koehler","year":"2009","journal-title":"Diabetes"},{"issue":"9","key":"2019041121542716400_B52","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00125-013-2957-2","article-title":"Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice","volume":"56","author":"Ellenbroek","year":"2013","journal-title":"Diabetologia"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/6\/1701\/17643661\/en.2017-00027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:11:14Z","timestamp":1750201874000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/6\/1701\/3063793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,8]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,3,8]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2017-00027","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,1]]},"published":{"date-parts":[[2017,3,8]]}}}